Trial Profile
Administration of Rifaximin to improve Liver Regeneration and Outcome following Major Liver Resection
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2019
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Liver disorders
- Focus Therapeutic Use
- Acronyms ARROW
- 20 Oct 2015 New trial record